Cite
MLA Citation
Lee Mozessohn et al.. “Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'.” Leukemia & lymphoma, vol. 61, no. 6, 2020, pp. 1445–1454. http://access.bl.uk/ark:/81055/vdc_100105290450.0x00003a